Nifty
:
25509.70
Sensex
:
83311.01
-87.95 (-0.34%)
-148.14 (-0.18%)
Nifty
Sensex
:
:
25509.70
83311.01
-87.95 (-0.34%)
-148.14 (-0.18%)

Syncom Formulations (India) Ltd.

Pharmaceuticals & Drugs

Rating :
64/99

BSE: 524470 | NSE: SYNCOMF

NSE BSE
16.09
06-Nov-2025
  • Open
  • High
  • Low
  • Previous Close
  •  16.37
  •  16.38
  •  16.01
  •  16.38
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1344105
  •  21693787.23
  •  23.87
  •  14.1

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,513.40
  • 26.29
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,517.27
  • N/A
  • 4.23

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 50.57%
  • 1.00%
  • 45.21%
  • FII
  • DII
  • Others
  • 0.1%
  • 0.00%
  • 3.12%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.72
  • 13.59
  • 27.52

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.50
  • 7.06
  • 22.16

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.91
  • 10.87
  • 35.05

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 37.15
  • 53.77
  • 47.53

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.57
  • 2.32
  • 3.87

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 22.14
  • 32.29
  • 30.46

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Net Sales
116.90
87.25
33.98%
148.88
74.57
99.65%
127.53
65.14
95.78%
102.31
63.84
60.26%
Expenses
101.09
76.80
31.63%
131.12
65.15
101.26%
112.80
57.78
95.22%
90.15
57.43
56.97%
EBITDA
15.81
10.45
51.29%
17.75
9.42
88.43%
14.73
7.36
100.14%
12.16
6.41
89.70%
EBIDTM
13.52%
11.98%
11.92%
12.64%
11.55%
11.30%
11.89%
10.04%
Other Income
6.04
1.34
350.75%
6.94
3.10
123.87%
4.04
4.55
-11.21%
4.15
4.00
3.75%
Interest
0.25
0.39
-35.90%
0.12
1.19
-89.92%
0.20
1.08
-81.48%
0.16
1.08
-85.19%
Depreciation
1.34
1.30
3.08%
1.29
1.30
-0.77%
1.31
1.45
-9.66%
1.30
0.88
47.73%
PBT
20.29
10.10
100.89%
23.30
10.03
132.30%
17.26
9.36
84.40%
14.85
8.45
75.74%
Tax
4.54
2.47
83.81%
5.61
2.63
113.31%
4.26
2.36
80.51%
3.74
1.94
92.78%
PAT
15.75
7.63
106.42%
17.69
7.40
139.05%
13.00
7.00
85.71%
11.11
6.51
70.66%
PATM
13.48%
8.75%
11.89%
9.93%
10.19%
10.75%
10.86%
10.20%
EPS
0.17
0.08
112.50%
0.19
0.08
137.50%
0.14
0.07
100.00%
0.12
0.07
71.43%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Net Sales
495.62
465.01
263.39
224.25
219.66
184.82
183.90
173.39
151.29
114.95
Net Sales Growth
70.43%
76.55%
17.45%
2.09%
18.85%
0.50%
6.06%
14.61%
31.61%
 
Cost Of Goods Sold
321.99
267.47
117.65
100.65
105.70
102.80
106.54
116.00
101.72
77.54
Gross Profit
173.63
197.55
145.74
123.60
113.96
82.03
77.36
57.40
49.57
37.41
GP Margin
35.03%
42.48%
55.33%
55.12%
51.88%
44.38%
42.07%
33.10%
32.76%
32.54%
Total Expenditure
435.16
410.88
233.74
204.35
199.63
168.27
167.23
155.18
135.02
104.30
Power & Fuel Cost
-
5.62
6.13
5.31
4.38
3.01
2.69
2.76
2.40
1.93
% Of Sales
-
1.21%
2.33%
2.37%
1.99%
1.63%
1.46%
1.59%
1.59%
1.68%
Employee Cost
-
50.56
33.57
24.44
20.73
14.45
13.48
13.38
11.35
10.06
% Of Sales
-
10.87%
12.75%
10.90%
9.44%
7.82%
7.33%
7.72%
7.50%
8.75%
Manufacturing Exp.
-
42.51
41.34
44.08
36.93
26.74
27.01
1.55
1.03
0.64
% Of Sales
-
9.14%
15.70%
19.66%
16.81%
14.47%
14.69%
0.89%
0.68%
0.56%
General & Admin Exp.
-
23.97
19.77
15.02
14.06
8.86
8.36
7.54
6.60
6.58
% Of Sales
-
5.15%
7.51%
6.70%
6.40%
4.79%
4.55%
4.35%
4.36%
5.72%
Selling & Distn. Exp.
-
20.20
14.68
14.29
17.32
12.09
8.90
13.72
11.84
7.47
% Of Sales
-
4.34%
5.57%
6.37%
7.88%
6.54%
4.84%
7.91%
7.83%
6.50%
Miscellaneous Exp.
-
0.55
0.61
0.56
0.50
0.31
0.26
0.23
0.08
0.08
% Of Sales
-
0.12%
0.23%
0.25%
0.23%
0.17%
0.14%
0.13%
0.05%
0.07%
EBITDA
60.45
54.13
29.65
19.90
20.03
16.55
16.67
18.21
16.27
10.65
EBITDA Margin
12.20%
11.64%
11.26%
8.87%
9.12%
8.95%
9.06%
10.50%
10.75%
9.26%
Other Income
21.17
17.43
13.53
14.60
11.99
2.79
2.67
1.98
1.12
1.15
Interest
0.73
0.86
4.47
3.40
1.93
0.33
0.14
0.29
0.47
0.52
Depreciation
5.24
5.19
4.72
4.54
3.95
3.12
3.00
3.40
2.99
2.83
PBT
75.70
65.51
33.98
26.56
26.15
15.89
16.20
16.49
13.93
8.45
Tax
18.15
16.08
8.64
6.50
6.39
5.34
5.75
5.88
4.61
2.79
Tax Rate
23.98%
24.54%
25.44%
24.46%
24.42%
33.63%
35.71%
37.62%
33.09%
33.02%
PAT
57.55
49.43
25.31
20.07
19.79
10.53
10.36
9.76
9.32
5.66
PAT before Minority Interest
57.55
49.43
25.31
20.07
19.79
10.53
10.36
9.76
9.32
5.66
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
11.61%
10.63%
9.61%
8.95%
9.01%
5.70%
5.63%
5.63%
6.16%
4.92%
PAT Growth
101.65%
95.30%
26.11%
1.41%
87.94%
1.64%
6.15%
4.72%
64.66%
 
EPS
0.61
0.53
0.27
0.21
0.21
0.11
0.11
0.10
0.10
0.06

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Shareholder's Funds
342.16
288.14
256.01
222.22
117.35
108.70
100.22
95.20
87.71
Share Capital
94.00
94.00
94.00
86.25
78.07
78.07
78.07
78.07
22.30
Total Reserves
248.16
194.14
162.01
130.94
39.29
30.63
22.16
17.13
65.40
Non-Current Liabilities
11.81
10.00
8.66
7.76
7.73
6.27
5.62
6.81
8.28
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
4.17
3.30
2.69
1.71
0.00
0.00
0.00
0.00
0.00
Current Liabilities
61.78
108.76
113.16
78.26
58.84
65.69
36.66
41.62
28.50
Trade Payables
42.80
24.14
20.45
13.79
32.27
46.94
19.92
29.35
19.43
Other Current Liabilities
7.75
6.26
6.91
2.83
5.84
3.67
1.63
0.86
1.72
Short Term Borrowings
4.58
72.49
83.18
57.79
12.45
5.62
6.08
3.30
2.05
Short Term Provisions
6.66
5.86
2.62
3.85
8.27
9.46
9.04
8.11
5.30
Total Liabilities
415.75
406.90
377.83
308.24
183.92
180.66
142.50
143.63
124.49
Net Block
77.57
72.42
43.40
46.61
55.04
45.85
45.78
50.26
50.47
Gross Block
145.62
135.66
101.92
100.68
91.98
82.41
80.43
77.18
74.40
Accumulated Depreciation
68.05
63.25
58.53
54.07
36.94
36.56
34.65
26.93
23.93
Non Current Assets
143.31
129.88
196.14
168.44
97.38
88.99
58.91
65.54
62.50
Capital Work in Progress
0.00
0.00
25.59
6.20
0.25
4.72
0.00
0.00
0.00
Non Current Investment
3.62
2.49
1.84
1.93
35.91
23.37
6.38
9.31
6.74
Long Term Loans & Adv.
1.20
1.01
2.26
2.25
6.18
15.05
6.75
5.97
5.29
Other Non Current Assets
13.59
6.63
75.73
64.33
0.00
0.00
0.00
0.00
0.00
Current Assets
272.44
277.01
181.69
139.80
86.54
91.66
83.59
78.09
61.99
Current Investments
89.22
63.70
62.26
41.40
0.00
0.00
0.00
0.00
0.00
Inventories
41.33
21.08
21.20
19.51
10.01
15.47
10.94
9.90
6.07
Sundry Debtors
107.55
103.30
75.51
67.55
45.99
46.00
31.16
29.42
28.94
Cash & Bank
0.71
67.87
8.63
0.39
6.52
5.69
6.77
5.28
3.76
Other Current Assets
33.63
1.48
4.46
2.73
24.02
24.51
34.72
33.50
23.22
Short Term Loans & Adv.
30.14
19.59
9.63
8.23
13.52
16.10
25.47
27.63
17.28
Net Current Assets
210.66
168.26
68.53
61.54
27.70
25.98
46.93
36.47
33.49
Total Assets
415.75
406.89
377.83
308.24
183.92
180.65
142.50
143.63
124.49

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Cash From Operating Activity
23.44
-5.96
10.53
16.33
13.84
24.07
0.08
6.73
5.78
PBT
65.51
33.98
26.56
26.15
15.88
16.10
16.49
13.93
8.45
Adjustment
-11.19
-3.48
-6.11
-7.16
0.71
1.14
2.59
2.36
2.24
Changes in Working Capital
-16.13
-28.37
-3.26
3.58
1.29
12.29
-12.51
-5.54
-2.58
Cash after chg. in Working capital
38.18
2.13
17.18
22.58
17.88
29.53
6.58
10.76
8.11
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-14.74
-8.08
-6.65
-6.25
-4.03
-5.35
-5.64
-4.02
-2.34
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
-0.01
-0.10
-0.86
0.00
0.00
Cash From Investing Activity
-18.20
83.02
-44.95
-27.07
-17.68
-22.74
0.74
-4.28
-0.32
Net Fixed Assets
-9.96
-8.15
-20.63
-14.65
-5.10
-6.70
-3.25
-2.78
Net Investments
-26.65
-2.09
-20.80
-12.37
-7.49
-16.99
2.83
-2.57
Others
18.41
93.26
-3.52
-0.05
-5.09
0.95
1.16
1.07
Cash from Financing Activity
-67.90
-14.56
35.00
8.29
4.67
-2.40
0.68
-0.93
-6.38
Net Cash Inflow / Outflow
-62.67
62.50
0.58
-2.45
0.83
-1.08
1.50
1.52
-0.92
Opening Cash & Equivalents
63.38
0.88
0.30
2.75
5.69
6.77
5.28
3.76
4.68
Closing Cash & Equivalent
0.71
63.38
0.88
0.30
6.52
5.69
6.77
5.28
3.76

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Book Value (Rs.)
3.64
3.07
2.72
2.52
1.50
1.39
1.28
1.22
1.12
ROA
12.02%
6.45%
5.85%
8.04%
5.78%
6.41%
6.82%
6.95%
4.54%
ROE
15.69%
9.30%
8.48%
11.83%
9.32%
9.91%
9.99%
10.19%
6.45%
ROCE
18.77%
10.98%
9.68%
13.72%
13.28%
14.72%
15.55%
15.29%
10.00%
Fixed Asset Turnover
3.31
2.22
2.21
2.28
2.12
2.28
2.20
2.00
1.55
Receivable days
82.75
123.89
116.42
94.33
90.83
75.88
63.71
70.22
91.86
Inventory Days
24.50
29.30
33.13
24.52
25.15
25.97
21.92
19.22
19.28
Payable days
45.68
69.17
62.08
79.52
91.28
73.89
59.55
67.54
70.98
Cash Conversion Cycle
61.57
84.02
87.47
39.33
24.70
27.96
26.08
21.90
40.17
Total Debt/Equity
0.01
0.25
0.32
0.27
0.11
0.05
0.06
0.03
0.02
Interest Cover
76.75
8.59
8.81
14.58
48.48
119.10
54.58
30.75
17.10

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014

News Update:


  • Syncom Formulations - Quarterly Results
    8th Aug 2025, 17:00 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.